Grant: Project Grant - Priority Announcement: Patient-Oriented Research
University of Ottawa
$100,000.00
Developing and implementing a core outcome set for adolescents and adults with phenylketonuria
EF 2025-26
Résumé
Rationale: Phenylketonuria (PKU) is a rare disease that requires lifelong treatment that usually includes a very restricted diet. A core outcome set (COS) is an agreed-upon set of outcomes recommended for measurement in all studies of a disease and that are meaningful to knowledge users (patients, caregivers, health care providers, researchers, and policy decision-makers). As new treatments for PKU are developed, a COS for PKU in adolescents and adults could help to support comparisons of studies and lead to better evidence about the effects of treatments on meaningful outcomes.
Aim: We propose to develop a COS (about 6 outcomes) for adolescents and adults with PKU in partnership with knowledge users, implement it in patient registries, and promote its use internationally.
Methods: We will work in close partnership with patients and caregivers. We will first establish a long list of potential outcomes through multiple sources, including a literature review and workshops with patients and caregivers. We will narrow down the outcomes and then conduct a Delphi Survey: an international group of patients, caregivers, and health care providers will provide their opinions about the importance of each outcome. At a subsequent consensus workshop, study team members and knowledge users will decide on the outcomes for inclusion in the COS. We will then identify approaches to measure each outcome. With knowledge users, we will evaluate the relevance of each approach and select those to recommend for use. Finally, we will integrate the core outcomes from the COS, along with the recommended measurement approaches, into the Canadian PKU Registry and a US-based PKU Registry. We will also develop a robust strategy to promote the use of the COS in international PKU research.
Value: As new developments transform PKU treatment for adolescents and adults, a rigorously-developed COS for adolescents and adults will be critical to produce meaningful evidence to support decision-making.
Programme
Project Grant - Priority Announcement: Patient-Oriented Research
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
555311
Name
Potter Elizabeth K
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Health Services Evaluation & Interventions Research 4
Projecttitle
Developing and implementing a core outcome set for adolescents and adults with phenylketonuria
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - Priority Announcement: Patient-Oriented Research
Keyworddelim
Adolescents; Adults; Clinical Research; Core Outcome Set; Outcomes; Phenylketonuria; Rare Disease; Transition To Adult Care
Abstract
Rationale: Phenylketonuria (PKU) is a rare disease that requires lifelong treatment that usually includes a very restricted diet. A core outcome set (COS) is an agreed-upon set of outcomes recommended for measurement in all studies of a disease and that are meaningful to knowledge users (patients, caregivers, health care providers, researchers, and policy decision-makers). As new treatments for PKU are developed, a COS for PKU in adolescents and adults could help to support comparisons of studies and lead to better evidence about the effects of treatments on meaningful outcomes.
Aim: We propose to develop a COS (about 6 outcomes) for adolescents and adults with PKU in partnership with knowledge users, implement it in patient registries, and promote its use internationally.
Methods: We will work in close partnership with patients and caregivers. We will first establish a long list of potential outcomes through multiple sources, including a literature review and workshops with patients and caregivers. We will narrow down the outcomes and then conduct a Delphi Survey: an international group of patients, caregivers, and health care providers will provide their opinions about the importance of each outcome. At a subsequent consensus workshop, study team members and knowledge users will decide on the outcomes for inclusion in the COS. We will then identify approaches to measure each outcome. With knowledge users, we will evaluate the relevance of each approach and select those to recommend for use. Finally, we will integrate the core outcomes from the COS, along with the recommended measurement approaches, into the Canadian PKU Registry and a US-based PKU Registry. We will also develop a robust strategy to promote the use of the COS in international PKU research.
Value: As new developments transform PKU treatment for adolescents and adults, a rigorously-developed COS for adolescents and adults will be critical to produce meaningful evidence to support decision-making.
Competitiondate
202509
Approvedterm2
1 yr 0 mth
Pinamesdelim
Potter, Elizabeth K; Mitchell, John J; Nimmo, Graeme; Pender, Amy; Smith, Maureen M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~